Key result
Cardiogenic shock in ADHF is linked to significantly higher inflammatory cytokine levels vs. stable HF.
Why the study?
Little is known about the impact of inflammatory changes in cardiogenic shock caused by acute decompensated heart failure.
Does the circulating inflammatory and cellular profile of patients with ADHF-CS differ distinctly from that of stable ambulatory HF and pre-CS patients?
Cross-Sectional (n=458)
No
Does the circulating inflammatory and cellular profile of patients with ADHF-CS differ distinctly from that of stable ambulatory HF and pre-CS patients?
p-value: p=<0.001
ADHF-CS is characterized by sequential inflammatory changes (transitioning from Th1 to Th17 immune profiles) compared to stable heart failure, offering a potential mechanism to risk-stratify ambulatory patients at risk of deterioration.
AIMS: The inflammatory profile of cardiogenic shock (CS) after myocardial infarction affects outcomes; however, little is known about the impact of inflammatory changes in CS caused by acute decompensated heart failure (ADHF-CS). We measured levels of inflammatory cytokines in patients with ADHF-CS admitted to a cardiac intensive care unit (CICU). METHODS: We identified patients admitted to our CICU with ADHF-CS who had consented to having biospecimens stored. We identified two comparator groups of patients with HF seen as outpatients with stored biospecimens: firstly, those who had no history of decompensation and did not develop CS during follow-up after sample acquisition (stable HF), and secondly, a group of patients who developed CS during follow-up (pre-CS). All samples underwent 48-plex cytokine and white blood cell differential testing with the differences between groups analysed by comparing means. RESULTS: Eighty-four ADHF-CS patients were identified who had samples obtained at a median of 2 [inter-quartile range (IQR) 0-7] days after CICU admission. Thirty-six pre-CS outpatients had samples taken 137 (IQR 41-258) days before admission with CS, and 338 stable HF control patients were included. Cytokine profiles differed between ADHF-CS and stable HF. Patients with CS had higher pro-inflammatory cytokine levels [including interleukin-1 (IL-1), interleukin-6 (IL-6) and interleukin-8 (IL-8)] and total white cell counts than stable HF patients. Analysis of the pre-CS outpatient group suggested an intermediate stage in subacute transition to CS. CONCLUSIONS: ADHF-CS is characterized by high levels of pro-inflammatory cytokines and total white count, compared with ambulatory HF. Decompensation from HF has two distinct inflammatory phases that may help identify outpatients at risk of CS.
No takes yet. Share an insight, caveat, or question.
Brahmbhatt et al. (2025) conducted a cross-sectional in Heart Failure and Cardiogenic Shock (n=458). Acute decompensated heart failure with cardiogenic shock (ADHF-CS) vs. Stable heart failure was evaluated on Circulating cytokine levels and white blood cell counts (p=<0.001). Acute decompensated heart failure with cardiogenic shock exhibited significantly higher levels of pro-inflammatory cytokines (including IL-1, IL-6, and IL-8) and total white cell counts compared to stable heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: